A detailed history of Bradley Foster & Sargent Inc transactions in Amgen Inc stock. As of the latest transaction made, Bradley Foster & Sargent Inc holds 16,243 shares of AMGN stock, worth $5.13 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
16,243
Previous 15,819 2.68%
Holding current value
$5.13 Million
Previous $4.5 Million 12.85%
% of portfolio
0.09%
Previous 0.08%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$262.75 - $319.31 $111,406 - $135,387
424 Added 2.68%
16,243 $5.08 Million
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $62,377 - $75,297
-232 Reduced 1.45%
15,819 $4.5 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $176,944 - $199,614
692 Added 4.51%
16,051 $4.62 Million
Q2 2023

Aug 08, 2023

BUY
$214.27 - $253.37 $430,896 - $509,527
2,011 Added 15.07%
15,359 $3.41 Million
Q1 2023

May 08, 2023

SELL
$225.79 - $275.2 $8,805 - $10,732
-39 Reduced 0.29%
13,348 $3.23 Million
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $49,012 - $62,276
-214 Reduced 1.57%
13,387 $3.52 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $673 - $759
-3 Reduced 0.02%
13,601 $3.07 Million
Q2 2022

Aug 11, 2022

BUY
$230.71 - $256.74 $262,317 - $291,913
1,137 Added 9.12%
13,604 $3.31 Million
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $150,419 - $166,403
686 Added 5.82%
12,467 $3.02 Million
Q4 2021

Mar 11, 2022

BUY
$198.88 - $227.6 $271,670 - $310,901
1,366 Added 13.12%
11,781 $2.65 Million
Q3 2021

Nov 10, 2021

BUY
$212.27 - $248.7 $75,143 - $88,039
354 Added 3.52%
10,415 $2.22 Million
Q2 2021

Aug 19, 2021

SELL
$233.58 - $259.14 $115,855 - $128,533
-496 Reduced 4.7%
10,061 $2.45 Million
Q1 2021

Apr 26, 2021

BUY
$221.91 - $258.6 $886,974 - $1.03 Million
3,997 Added 60.93%
10,557 $2.63 Million
Q4 2020

Feb 11, 2021

SELL
$216.38 - $257.67 $41,761 - $49,730
-193 Reduced 2.86%
6,560 $1.51 Million
Q3 2020

Oct 26, 2020

SELL
$234.65 - $260.95 $54,438 - $60,540
-232 Reduced 3.32%
6,753 $1.72 Million
Q1 2020

May 07, 2020

SELL
$182.24 - $241.7 $22,415 - $29,729
-123 Reduced 1.73%
6,985 $1.42 Million
Q4 2019

Jan 29, 2020

BUY
$189.21 - $243.2 $32,354 - $41,587
171 Added 2.47%
7,108 $1.71 Million
Q3 2019

Oct 30, 2019

SELL
$174.11 - $208.62 $73,996 - $88,663
-425 Reduced 5.77%
6,937 $1.34 Million
Q2 2019

Aug 08, 2019

SELL
$166.7 - $195.41 $1.06 Million - $1.25 Million
-6,383 Reduced 46.44%
7,362 $1.36 Million
Q1 2019

May 02, 2019

SELL
$180.87 - $203.88 $153,016 - $172,482
-846 Reduced 5.8%
13,745 $2.61 Million
Q4 2018

Jan 30, 2019

BUY
$178.4 - $208.25 $9,098 - $10,620
51 Added 0.35%
14,591 $2.84 Million
Q3 2018

Oct 31, 2018

SELL
$185.29 - $208.89 $64,851 - $73,111
-350 Reduced 2.35%
14,540 $3.01 Million
Q2 2018

Jul 31, 2018

BUY
$166.05 - $186.51 $1.22 Million - $1.37 Million
7,371 Added 98.03%
14,890 $2.75 Million
Q1 2018

May 07, 2018

BUY
$169.43 - $198.0 $43,204 - $50,490
255 Added 3.51%
7,519 $1.28 Million
Q4 2017

Feb 06, 2018

SELL
$168.79 - $188.59 $53,675 - $59,971
-318 Reduced 4.19%
7,264 $1.26 Million
Q3 2017

Nov 03, 2017

BUY
$167.29 - $191.0 $1.27 Million - $1.45 Million
7,582
7,582 $1.41 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Bradley Foster & Sargent Inc Portfolio

Follow Bradley Foster & Sargent Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bradley Foster & Sargent Inc with notifications on news.